Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country. - Baş O; Sert L; Balçık OY; Tokatli M; Boyraz NE; Kavgaci G; Şahin TK; Güven DC; Arık Z; Işikdoğan A; Erman M (Expert review of anticancer therapy, 2025)